XML 101 R39.htm IDEA: XBRL DOCUMENT
v3.20.1

Note 16 - Quarterly Financial Information (Unaudited) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Notes Tables |
Quarterly Financial Information [Table Text Block] |
|  | Balance Sheet March 31, 2018 |
(In thousands, except share and per share data) |  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 7,033 |  |  | $ | - |  |  |  | $ | 7,033 |
Accounts receivable, trade, net of allowance for doubtful accounts of $6 at March 31, 2018 |  |  | 1,043 |  |  |  | - |  |  |  |  | 1,043 |
Inventories |  |  | 1,837 |  |  |  | - |  |  |  |  | 1,837 |
Prepaid expenses and other current assets |  |  | 331 |  |  |  | - |  |  |  |  | 331 |
Total current assets |  |  | 10,244 |  |  |  | - |  |  |  |  | 10,244 |
Property and equipment, net |  |  |  |  |  |  | - |  |  |  |  |  |
Leasehold improvements |  |  | 1,284 |  |  |  | - |  |  |  |  | 1,284 |
Furniture and computer equipment |  |  | 692 |  |  |  | - |  |  |  |  | 692 |
Manufacturing and other equipment |  |  | 1,195 |  |  |  | - |  |  |  |  | 1,195 |
Subtotal |  |  | 3,171 |  |  |  | - |  |  |  |  | 3,171 |
Less: Accumulated depreciation |  |  | (2,084 | ) |  |  | - |  |  |  |  | (2,084 | )
Net property and equipment |  |  | 1,087 |  |  |  | - |  |  |  |  | 1,087 |
Investment in SAVSU |  |  | 926 |  |  |  | - |  |  |  |  | 926 |
Long-term deposits |  |  | 36 |  |  |  | - |  |  |  |  | 36 |
Total assets |  | $ | 12,293 |  |  | $ | - |  |  |  | $ | 12,293 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  |  | 586 |  |  |  | - |  |  |  |  | 586 |
Accrued expenses and other current liabilities |  |  | 204 |  |  |  | - |  |  |  |  | 204 |
Accrued compensation |  |  | 392 |  |  |  | - |  |  |  |  | 392 |
Deferred rent, current portion |  |  | 130 |  |  |  | - |  |  |  |  |  |
Total current liabilities |  |  | 1,312 |  |  |  | - |  |  |  |  | 1,312 |
Deferred rent, long-term |  |  | 457 |  |  |  | - |  |  |  |  | 457 |
Warrant liability |  |  | - |  |  |  | 14,725 |  | (a) |  |  | 14,725 |
Other long-term liabilities |  |  | 52 |  |  |  | - |  |  |  |  | 52 |
Total liabilities |  |  | 1,821 |  |  |  | 14,725 |  |  |  |  | 16,546 |
Commitments and Contingencies |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders’ equity (deficit) |  |  |  |  |  |  |  |  |  |  |  |  |
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 4,250 shares issued and outstanding at March 31, 2018 |  |  | - |  |  |  | - |  |  |  |  | - |
Common stock, $0.001 par value; 150,000,000 shares authorized, 14,145,413 shares issued and outstanding at March 31, 2018 |  |  | 14 |  |  |  | - |  |  |  |  | 14 |
Additional paid-in capital |  |  | 84,518 |  |  |  | (20,501 | ) | (a) |  |  | 64,017 |
Accumulated deficit |  |  | (74,060 | ) |  |  | 5,776 |  | (a) |  |  | (68,284 | )
Total shareholders’ equity (deficit) |  |  | 10,472 |  |  |  | (14,725 | ) |  |  |  | (4,253 | )
Total liabilities and shareholders’ equity |  | $ | 12,293 |  |  | $ | - |  |  |  | $ | 12,293 |
|  | Balance Sheet June 30, 2018 |
(In thousands, except share and per share data) |  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 14,167 |  |  | $ | - |  |  |  | $ | 14,167 |
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at June 30, 2018 |  |  | 2,166 |  |  |  | - |  |  |  |  | 2,166 |
Inventories |  |  | 2,122 |  |  |  | - |  |  |  |  | 2,122 |
Prepaid expenses and other current assets |  |  | 352 |  |  |  | - |  |  |  |  | 352 |
Total current assets |  |  | 18,807 |  |  |  | - |  |  |  |  | 18,807 |
Property and equipment, net |  |  |  |  |  |  | - |  |  |  |  |  |
Leasehold improvements |  |  | 1,284 |  |  |  | - |  |  |  |  | 1,284 |
Furniture and computer equipment |  |  | 693 |  |  |  | - |  |  |  |  | 693 |
Manufacturing and other equipment |  |  | 1,230 |  |  |  | - |  |  |  |  | 1,230 |
Subtotal |  |  | 3,207 |  |  |  | - |  |  |  |  | 3,207 |
Less: Accumulated depreciation |  |  | (2,163 | ) |  |  | - |  |  |  |  | (2,163 | )
Net property and equipment |  |  | 1,044 |  |  |  | - |  |  |  |  | 1,044 |
Investment in SAVSU |  |  | 1,900 |  |  |  | - |  |  |  |  | 1,900 |
Long-term deposits |  |  | 36 |  |  |  | - |  |  |  |  | 36 |
Total assets |  | $ | 21,787 |  |  | $ | - |  |  |  | $ | 21,787 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  |  | 843 |  |  |  | - |  |  |  |  | 843 |
Accrued expenses and other current liabilities |  |  | 173 |  |  |  | - |  |  |  |  | 173 |
Accrued compensation |  |  | 518 |  |  |  | - |  |  |  |  | 518 |
Deferred rent, current portion |  |  | 130 |  |  |  | - |  |  |  |  |  |
Total current liabilities |  |  | 1,664 |  |  |  | - |  |  |  |  | 1,664 |
Deferred rent, long-term |  |  | 423 |  |  |  | - |  |  |  |  | 423 |
Warrant liability |  |  | - |  |  |  | 32,599 |  | (a) |  |  | 32,599 |
Other long-term liabilities |  |  | 45 |  |  |  | - |  |  |  |  | 45 |
Total liabilities |  |  | 2,132 |  |  |  | 32,599 |  |  |  |  | 34,731 |
Commitments and Contingencies |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders’ equity (deficit) |  |  |  |  |  |  |  |  |  |  |  |  |
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 4,250 shares issued and outstanding at June 30, 2018 |  |  | - |  |  |  | - |  |  |  |  | - |
Common stock, $0.001 par value; 150,000,000 shares authorized, 16,107,505 shares issued and outstanding at June 30, 2018 |  |  | 16 |  |  |  | - |  |  |  |  | 16 |
Additional paid-in capital |  |  | 92,654 |  |  |  | (10,892 | ) | (a) |  |  | 81,762 |
Accumulated deficit |  |  | (73,015 | ) |  |  | (21,707 | ) | (a) |  |  | (94,722 | )
Total shareholders’ equity (deficit) |  |  | 19,655 |  |  |  | (32,599 | ) |  |  |  | (12,944 | )
Total liabilities and shareholders’ equity |  | $ | 21,787 |  |  | $ | - |  |  |  | $ | 21,787 |
|  | Balance Sheet September 30, 2018 |
(In thousands, except share and per share data) |  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 32,381 |  |  | $ | - |  |  |  | $ | 32,381 |
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at September 30, 2018 |  |  | 2,699 |  |  |  | - |  |  |  |  | 2,699 |
Inventories |  |  | 2,911 |  |  |  | - |  |  |  |  | 2,911 |
Prepaid expenses and other current assets |  |  | 298 |  |  |  | - |  |  |  |  | 298 |
Total current assets |  |  | 38,289 |  |  |  | - |  |  |  |  | 38,289 |
Property and equipment, net |  |  |  |  |  |  | - |  |  |  |  |  |
Leasehold improvements |  |  | 1,284 |  |  |  | - |  |  |  |  | 1,284 |
Furniture and computer equipment |  |  | 706 |  |  |  | - |  |  |  |  | 706 |
Manufacturing and other equipment |  |  | 1,511 |  |  |  | - |  |  |  |  | 1,511 |
Subtotal |  |  | 3,501 |  |  |  | - |  |  |  |  | 3,501 |
Less: Accumulated depreciation |  |  | (2,234 | ) |  |  | - |  |  |  |  | (2,234 | )
Net property and equipment |  |  | 1,267 |  |  |  | - |  |  |  |  | 1,267 |
Investment in SAVSU |  |  | 6,857 |  |  |  | - |  |  |  |  | 6,857 |
Long-term deposits |  |  | 36 |  |  |  | - |  |  |  |  | 36 |
Total assets |  | $ | 46,449 |  |  | $ | - |  |  |  | $ | 46,449 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  |  | 1,090 |  |  |  | - |  |  |  |  | 1,090 |
Accrued expenses and other current liabilities |  |  | 162 |  |  |  | - |  |  |  |  | 162 |
Accrued compensation |  |  | 713 |  |  |  | - |  |  |  |  | 713 |
Deferred rent, current portion |  |  | 130 |  |  |  | - |  |  |  |  |  |
Total current liabilities |  |  | 2,095 |  |  |  | - |  |  |  |  | 2,095 |
Deferred rent, long-term |  |  | 386 |  |  |  | - |  |  |  |  | 386 |
Warrant liability |  |  | - |  |  |  | 50,425 |  | (a) |  |  | 50,425 |
Other long-term liabilities |  |  | 38 |  |  |  | - |  |  |  |  | 38 |
Total liabilities |  |  | 2,519 |  |  |  | 50,425 |  |  |  |  | 52,944 |
Commitments and Contingencies |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders’ equity (deficit) |  |  |  |  |  |  |  |  |  |  |  |  |
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 4,250 shares issued and outstanding at September 30, 2018 |  |  | - |  |  |  | - |  |  |  |  | - |
Common stock, $0.001 par value; 150,000,000 shares authorized, 18,237,425 shares issued and outstanding at September 30, 2018 |  |  | 18 |  |  |  | - |  |  |  |  | 18 |
Additional paid-in capital |  |  | 115,776 |  |  |  | (3,021 | ) | (a) |  |  | 112,755 |
Accumulated deficit |  |  | (71,864 | ) |  |  | (47,404 | ) | (a) |  |  | (119,268 | )
Total shareholders’ equity (deficit) |  |  | 43,930 |  |  |  | (50,425 | ) |  |  |  | (6,495 | )
Total liabilities and shareholders’ equity |  | $ | 46,449 |  |  | $ | - |  |  |  | $ | 46,449 |
|  | Balance Sheet March 31, 2019 |
(In thousands, except share and per share data) |  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 31,824 |  |  | $ | - |  |  |  | $ | 31,824 |
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at March 31, 2019 |  |  | 2,927 |  |  |  | - |  |  |  |  | 2,927 |
Inventories |  |  | 4,060 |  |  |  | - |  |  |  |  | 4,060 |
Prepaid expenses and other current assets |  |  | 346 |  |  |  | - |  |  |  |  | 346 |
Total current assets |  |  | 39,157 |  |  |  | - |  |  |  |  | 39,157 |
Property and equipment, net |  |  |  |  |  |  |  |  |  |  |  |  |
Leasehold improvements |  |  | 1,284 |  |  |  | - |  |  |  |  | 1,284 |
Furniture and computer equipment |  |  | 704 |  |  |  | - |  |  |  |  | 704 |
Manufacturing and other equipment |  |  | 1,803 |  |  |  | - |  |  |  |  | 1,803 |
Subtotal |  |  | 3,791 |  |  |  | - |  |  |  |  | 3,791 |
Less: Accumulated depreciation |  |  | (2,424 | ) |  |  | - |  |  |  |  | (2,424 | )
Net property and equipment |  |  | 1,367 |  |  |  | - |  |  |  |  | 1,367 |
Operating lease right-of-use assets |  |  | 1,196 |  |  |  | - |  |  |  |  | 1,196 |
Investment in SAVSU |  |  | 6,317 |  |  |  | - |  |  |  |  | 6,317 |
Long-term deposits |  |  | 36 |  |  |  | - |  |  |  |  | 36 |
Total assets |  | $ | 48,073 |  |  | $ | - |  |  |  | $ | 48,073 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  |  | 1,264 |  |  |  | - |  |  |  |  | 1,264 |
Accrued expenses and other current liabilities |  |  | 142 |  |  |  | - |  |  |  |  | 142 |
Accrued compensation |  |  | 630 |  |  |  | - |  |  |  |  | 630 |
Lease liability - operating, current position |  |  | 651 |  |  |  | - |  |  |  |  | 651 |
Lease liability - financing, current position |  |  | 14 |  |  |  | - |  |  |  |  | 14 |
Total current liabilities |  |  | 2,701 |  |  |  | - |  |  |  |  | 2,701 |
Long-term lease liability - operating |  |  | 980 |  |  |  | - |  |  |  |  | 980 |
Long-term lease liability - financing |  |  | 13 |  |  |  | - |  |  |  |  | 13 |
Warrant liability |  |  | - |  |  |  | 48,106 |  | (a) |  |  | 48,106 |
Other long-term liabilities |  |  | 13 |  |  |  | - |  |  |  |  | 13 |
Total liabilities |  |  | 3,707 |  |  |  | 48,106 |  |  |  |  | 51,813 |
Commitments and Contingencies |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders’ equity (deficit) |  |  |  |  |  |  |  |  |  |  |  |  |
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding at March 31, 2019 |  |  | - |  |  |  | - |  |  |  |  | - |
Common stock, $0.001 par value; 150,000,000 shares authorized, 18,717,095 shares issued and outstanding at March 31, 2019 |  |  | 19 |  |  |  | - |  |  |  |  | 19 |
Additional paid-in capital |  |  | 114,951 |  |  |  | (1,154 | ) | (a) |  |  | 113,797 |
Accumulated deficit |  |  | (70,604 | ) |  |  | (46,952 | ) | (a) |  |  | (117,556 | )
Total shareholders’ equity (deficit) |  |  | 44,366 |  |  |  | (48,106 | ) |  |  |  | (3,740 | )
Total liabilities and shareholders’ equity |  | $ | 48,073 |  |  | $ | - |  |  |  | $ | 48,073 |
|  | Balance Sheet June 30, 2019 |
(In thousands, except share and per share data) |  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 19,617 |  |  | $ | - |  |  |  | $ | 19,617 |
Accounts receivable, trade, net of allowance for doubtful accounts of $26 at June 30, 2019 |  |  | 3,832 |  |  |  | - |  |  |  |  | 3,832 |
Inventories |  |  | 5,306 |  |  |  | - |  |  |  |  | 5,306 |
Prepaid expenses and other current assets |  |  | 384 |  |  |  | - |  |  |  |  | 384 |
Total current assets |  |  | 29,139 |  |  |  | - |  |  |  |  | 29,139 |
Property and equipment, net |  |  |  |  |  |  |  |  |  |  |  |  |
Leasehold improvements |  |  | 1,284 |  |  |  | - |  |  |  |  | 1,284 |
Furniture and computer equipment |  |  | 577 |  |  |  | - |  |  |  |  | 577 |
Manufacturing and other equipment |  |  | 1,733 |  |  |  | - |  |  |  |  | 1,733 |
Subtotal |  |  | 3,594 |  |  |  | - |  |  |  |  | 3,594 |
Less: Accumulated depreciation |  |  | (2,276 | ) |  |  | - |  |  |  |  | (2,276 | )
Net property and equipment |  |  | 1,318 |  |  |  | - |  |  |  |  | 1,318 |
Operating lease right-of-use assets |  |  | 1,079 |  |  |  | - |  |  |  |  | 1,079 |
Investment in SAVSU |  |  | 6,100 |  |  |  | - |  |  |  |  | 6,100 |
Intangible assets, net |  |  | 4,446 |  |  |  | (430 | ) | (c) |  |  | 4,016 |
Goodwill |  |  | 9,524 |  |  |  | (9 | ) | (b),(c) |  |  | 9,515 |
Long-term deposits |  |  | 136 |  |  |  | - |  |  |  |  | 136 |
Total assets |  | $ | 51,742 |  |  | $ | (439 | ) |  |  | $ | 51,303 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  |  | 876 |  |  |  | - |  |  |  |  | 876 |
Accrued expenses and other current liabilities |  |  | 204 |  |  |  | - |  |  |  |  | 204 |
Accrued compensation |  |  | 963 |  |  |  | - |  |  |  |  | 963 |
Lease liability - operating, current position |  |  | 665 |  |  |  | - |  |  |  |  | 665 |
Lease liability - financing, current position |  |  | 14 |  |  |  | - |  |  |  |  | 14 |
Contingent consideration - current |  |  | 371 |  |  |  | 70 |  | (b) |  |  | 441 |
Total current liabilities |  |  | 3,093 |  |  |  | 70 |  |  |  |  | 3,163 |
Long-term lease liability - operating |  |  | 806 |  |  |  | - |  |  |  |  | 806 |
Long-term lease liability - financing |  |  | 10 |  |  |  | - |  |  |  |  | 10 |
Warrant liability |  |  | - |  |  |  | 44,194 |  | (a) |  |  | 44,194 |
Other long-term liabilities |  |  | 7 |  |  |  | - |  |  |  |  | 7 |
Contingent consideration - long-term |  |  | 1,560 |  |  |  | (509 | ) | (b) |  |  | 1,051 |
Total liabilities |  |  | 5,476 |  |  |  | 43,755 |  |  |  |  | 49,231 |
Commitments and Contingencies |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders’ equity (deficit) |  |  |  |  |  |  |  |  |  |  |  |  |
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding at June 30, 2019 |  |  | - |  |  |  | - |  |  |  |  | - |
Common stock, $0.001 par value; 150,000,000 shares authorized, 18,898,609 shares issued and outstanding at June 30, 2019 |  |  | 19 |  |  |  | - |  |  |  |  | 19 |
Additional paid-in capital |  |  | 116,013 |  |  |  | (656 | ) | (a) |  |  | 115,357 |
Accumulated deficit |  |  | (69,766 | ) |  |  | (43,538 | ) | (a),(d) |  |  | (113,304 | )
Total shareholders’ equity (deficit) |  |  | 46,266 |  |  |  | (44,194 | ) |  |  |  | 2,072 |
Total liabilities and shareholders’ equity |  | $ | 51,742 |  |  | $ | (439 | ) |  |  | $ | 51,303 |
|  | Balance Sheet September 30, 2019 |
(In thousands, except share and per share data) |  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 21,205 |  |  | $ | - |  |  |  | $ | 21,205 |
Accounts receivable, trade, net of allowance for doubtful accounts of $68 at September 30, 2019 |  |  | 4,313 |  |  |  | - |  |  |  |  | 4,313 |
Inventories |  |  | 5,694 |  |  |  | - |  |  |  |  | 5,694 |
Prepaid expenses and other current assets |  |  | 855 |  |  |  | - |  |  |  |  | 855 |
Total current assets |  |  | 32,067 |  |  |  | - |  |  |  |  | 32,067 |
Property and equipment, net |  |  |  |  |  |  | - |  |  |  |  |  |
Leasehold improvements |  |  | 1,599 |  |  |  | - |  |  |  |  | 1,599 |
Furniture and computer equipment |  |  | 588 |  |  |  | - |  |  |  |  | 588 |
Manufacturing and other equipment |  |  | 2,247 |  |  |  | - |  |  |  |  | 2,247 |
Subtotal |  |  | 4,434 |  |  |  | - |  |  |  |  | 4,434 |
Less: Accumulated depreciation |  |  | (2,298 | ) |  |  | - |  |  |  |  | (2,298 | )
Net property and equipment |  |  | 2,136 |  |  |  | - |  |  |  |  | 2,136 |
Assets held for rent, net |  |  | 2,976 |  |  |  |  |  |  |  |  | 2,976 |
Operating lease right-of-use assets |  |  | 1,177 |  |  |  | - |  |  |  |  | 1,177 |
Investment in SAVSU |  |  | 1,000 |  |  |  | - |  |  |  |  | 1,000 |
Intangible assets, net |  |  | 16,485 |  |  |  | (430 | ) | (c) |  |  | 16,055 |
Goodwill |  |  | 28,351 |  |  |  | (9 | ) | (b),(c) |  |  | 28,342 |
Long-term deposits |  |  | 36 |  |  |  | - |  |  |  |  | 36 |
Total assets |  | $ | 84,228 |  |  | $ | (439 | ) |  |  | $ | 83,789 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  |  | 1,570 |  |  |  | - |  |  |  |  | 1,570 |
Accrued expenses and other current liabilities |  |  | 642 |  |  |  | - |  |  |  |  | 642 |
Accrued compensation |  |  | 1,576 |  |  |  | - |  |  |  |  | 1,576 |
Lease liability - operating, current position |  |  | 771 |  |  |  | - |  |  |  |  | 771 |
Lease liability - financing, current position |  |  | 14 |  |  |  | - |  |  |  |  | 14 |
Contingent consideration - current |  |  | 371 |  |  |  | 70 |  | (b) |  |  | 441 |
Total current liabilities |  |  | 4,944 |  |  |  | 70 |  |  |  |  | 5,014 |
Long-term lease liability - operating |  |  | 753 |  |  |  | - |  |  |  |  | 753 |
Long-term lease liability - financing |  |  | 6 |  |  |  | - |  |  |  |  | 6 |
Warrant liability |  |  | - |  |  |  | 41,771 |  | (a) |  |  | 41,771 |
Other long-term liabilities |  |  | 3 |  |  |  | - |  |  |  |  | 3 |
Contingent consideration - long-term |  |  | 1,560 |  |  |  | (509 | ) | (b) |  |  | 1,051 |
Total liabilities |  |  | 7,266 |  |  |  | 41,332 |  |  |  |  | 48,598 |
Commitments and Contingencies |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders’ equity (deficit) |  |  |  |  |  |  |  |  |  |  |  |  |
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding at September 30, 2019 |  |  |  |  |  |  | - |  |  |  |  | - |
Common stock, $0.001 par value; 150,000,000 shares authorized, 20,344,825 shares issued and outstanding at June 30, 2019 |  |  | 20 |  |  |  | - |  |  |  |  | 20 |
Additional paid-in capital |  |  | 137,392 |  |  |  | 814 |  | (a) |  |  | 138,206 |
Accumulated deficit |  |  | (60,450 | ) |  |  | (42,585 | ) | (a),(d) |  |  | (103,035 | )
Total shareholders’ equity (deficit) |  |  | 76,962 |  |  |  | (41,771 | ) |  |  |  | 35,191 |
Total liabilities and shareholders’ equity |  | $ | 84,228 |  |  | $ | (439 | ) |  |  | $ | 83,789 |
(In thousands, except per share and share data ) |  | Statement of Operations Three Months Ending March 31, 2018 |
|  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |
Revenue |  | $ | 3,815 |  |  | $ | - |  |  |  | $ | 3,815 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of revenue |  |  | 1,364 |  |  |  | - |  |  |  |  | 1,364 |
Research and development |  |  | 346 |  |  |  | - |  |  |  |  | 346 |
Sales and marketing |  |  | 612 |  |  |  | - |  |  |  |  | 612 |
General and administrative |  |  | 1,353 |  |  |  | - |  |  |  |  | 1,353 |
Total operating expenses |  |  | 3,675 |  |  |  | - |  |  |  |  | 3,675 |
Operating income (loss) |  |  | 140 |  |  |  | - |  |  |  |  | 140 |
Other income (expenses) |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of warrant liability |  |  | - |  |  |  | 4,870 |  | (a) |  |  | 4,870 |
Interest income |  |  | 8 |  |  |  | - |  |  |  |  | 8 |
Interest expense |  |  | (1 | ) |  |  | - |  |  |  |  | (1 | )
Loss from equity-method investment in SAVSU |  |  | (144 | ) |  |  | - |  |  |  |  | (144 | )
Total other income (expenses) |  |  | (137 | ) |  |  | 4,870 |  |  |  |  | 4,733 |
Net income (loss) |  |  | 3 |  |  |  | 4,870 |  |  |  |  | 4,873 |
Less: Preferred stock dividends |  |  | (106 | ) |  |  | - |  |  |  |  | (106 | )
Net income (loss) attributable to common stockholders |  | $ | (103 | ) |  | $ | 4,870 |  |  |  | $ | 4,767 |
Net income (loss) attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (103 | ) |  | $ | 3,250 |  |  |  | $ | 3,147 |
Diluted |  | $ | (103 | ) |  | $ | (179 | ) |  |  | $ | (282 | )
Earnings per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (0.01 | ) |  | $ | 0.23 |  |  |  | $ | 0.22 |
Diluted |  | $ | (0.01 | ) |  | $ | (0.01 | ) |  |  | $ | (0.02 | )
Weighted average shares used to compute earnings per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 14,098,610 |  |  |  | - |  |  |  |  | 14,098,610 |
Diluted |  |  | 14,098,610 |  |  |  | - |  |  |  |  | 14,098,610 |
(In thousands, except per share and share data) |  | Statement of Operations Three Months Ending June 30, 2018 |  |  | Statement of Operations Six Months Ending June 30, 2018 |
|  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |  |  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |
Revenue |  | $ | 5,178 |  |  | $ | - |  |  |  | $ | 5,178 |  |  | $ | 8,993 |  |  | $ | - |  |  |  | $ | 8,993 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of revenue |  |  | 1,537 |  |  |  | - |  |  |  |  | 1,537 |  |  |  | 2,901 |  |  |  | - |  |  |  |  | 2,901 |
Research and development |  |  | 325 |  |  |  | - |  |  |  |  | 325 |  |  |  | 671 |  |  |  | - |  |  |  |  | 671 |
Sales and marketing |  |  | 641 |  |  |  | - |  |  |  |  | 641 |  |  |  | 1,253 |  |  |  | - |  |  |  |  | 1,253 |
General and administrative |  |  | 1,390 |  |  |  | - |  |  |  |  | 1,390 |  |  |  | 2,744 |  |  |  | - |  |  |  |  | 2,744 |
Total operating expenses |  |  | 3,893 |  |  |  | - |  |  |  |  | 3,893 |  |  |  | 7,569 |  |  |  | - |  |  |  |  | 7,569 |
Operating income (loss) |  |  | 1,285 |  |  |  | - |  |  |  |  | 1,285 |  |  |  | 1,424 |  |  |  | - |  |  |  |  | 1,424 |
Other income (expenses) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of warrant liability |  |  | - |  |  |  | (27,485 | ) | (a) |  |  | (27,485 | ) |  |  | - |  |  |  | (22,615 | ) | (a) |  |  | (22,615 | )
Interest income |  |  | 32 |  |  |  | - |  |  |  |  | 32 |  |  |  | 41 |  |  |  | - |  |  |  |  | 41 |
Interest expense |  |  | (1 | ) |  |  | - |  |  |  |  | (1 | ) |  |  | (1 | ) |  |  | - |  |  |  |  | (1 | )
Loss from equity-method investment in SAVSU |  |  | (177 | ) |  |  | - |  |  |  |  | (177 | ) |  |  | (321 | ) |  |  | - |  |  |  |  | (321 | )
Total other income (expenses) |  |  | (146 | ) |  |  | (27,485 | ) |  |  |  | (27,631 | ) |  |  | (281 | ) |  |  | (22,615 | ) |  |  |  | (22,896 | )
Net income (loss) |  |  | 1,139 |  |  |  | (27,485 | ) |  |  |  | (26,346 | ) |  |  | 1,143 |  |  |  | (22,615 | ) |  |  |  | (21,472 | )
Less: Preferred stock dividends |  |  | (93 | ) |  |  | - |  |  |  |  | (93 | ) |  |  | (200 | ) |  |  | - |  |  |  |  | (200 | )
Net income (loss) attributable to common stockholders |  |  | 1,046 |  |  |  | (27,485 | ) |  |  |  | (26,439 | ) |  |  | 943 |  |  |  | (22,615 | ) |  |  |  | (21,672 | )
Net income (loss) attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 1,046 |  |  | $ | (27,485 | ) |  |  | $ | (26,439 | ) |  | $ | 943 |  |  | $ | (22,614 | ) |  |  | $ | (21,672 | )
Diluted |  | $ | 1,046 |  |  | $ | (27,485 | ) |  |  | $ | (26,439 | ) |  | $ | 943 |  |  | $ | (22,614 | ) |  |  | $ | (21,672 | )
Earnings per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.07 |  |  | $ | (1.81 | ) |  |  | $ | (1.74 | ) |  | $ | 0.06 |  |  | $ | (1.54 | ) |  |  | $ | (1.48 | )
Diluted |  | $ | 0.05 |  |  | $ | (1.79 | ) |  |  | $ | (1.74 | ) |  | $ | 0.05 |  |  | $ | (1.53 | ) |  |  | $ | (1.48 | )
Weighted average shares used to compute earnings per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 15,180,169 |  |  |  | - |  |  |  |  | 15,180,169 |  |  |  | 14,642,378 |  |  |  | - |  |  |  |  | 14,642,378 |
Diluted |  |  | 20,374,358 |  |  |  | (5,194,189 | ) |  |  |  | 15,180,169 |  |  |  | 19,063,595 |  |  |  | (4,421,217 | ) |  |  |  | 14,642,378 |
(In thousands, except per share and share data) |  | Statement of Operations Three Months Ending September 30, 2018 |  |  | Statement of Operations Nine Months Ending September 30, 2018 |
|  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |  |  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |
Revenue |  | $ | 5,293 |  |  | $ | - |  |  |  | $ | 5,293 |  |  | $ | 14,286 |  |  | $ | - |  |  |  | $ | 14,286 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of revenue |  |  | 1,606 |  |  |  | - |  |  |  |  | 1,606 |  |  |  | 4,507 |  |  |  | - |  |  |  |  | 4,507 |
Research and development |  |  | 312 |  |  |  | - |  |  |  |  | 312 |  |  |  | 983 |  |  |  | - |  |  |  |  | 983 |
Sales and marketing |  |  | 725 |  |  |  | - |  |  |  |  | 725 |  |  |  | 1,978 |  |  |  | - |  |  |  |  | 1,978 |
General and administrative |  |  | 1,455 |  |  |  | - |  |  |  |  | 1,455 |  |  |  | 4,199 |  |  |  | - |  |  |  |  | 4,199 |
Total operating expenses |  |  | 4,098 |  |  |  | - |  |  |  |  | 4,098 |  |  |  | 11,667 |  |  |  | - |  |  |  |  | 11,667 |
Operating income (loss) |  |  | 1,195 |  |  |  | - |  |  |  |  | 1,195 |  |  |  | 2,619 |  |  |  | - |  |  |  |  | 2,619 |
Other income (expenses) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of warrant liability |  |  | - |  |  |  | (25,696 | ) | (a) |  |  | (25,696 | ) |  |  | - |  |  |  | (48,311 | ) | (a) |  |  | (48,311 | )
Interest income |  |  | 80 |  |  |  | - |  |  |  |  | 80 |  |  |  | 121 |  |  |  | - |  |  |  |  | 121 |
Interest expense |  |  | (1 | ) |  |  | - |  |  |  |  | (1 | ) |  |  | (4 | ) |  |  | - |  |  |  |  | (4 | )
Loss from equity-method investment in SAVSU |  |  | (43 | ) |  |  | - |  |  |  |  | (43 | ) |  |  | (363 | ) |  |  | - |  |  |  |  | (363 | )
Total other income (expenses) |  |  | 36 |  |  |  | (25,696 | ) |  |  |  | (25,660 | ) |  |  | (246 | ) |  |  | (48,311 | ) |  |  |  | (48,557 | )
Net income (loss) |  |  | 1,231 |  |  |  | (25,696 | ) |  |  |  | (24,465 | ) |  |  | 2,373 |  |  |  | (48,311 | ) |  |  |  | (45,938 | )
Less: Preferred stock dividends |  |  | (80 | ) |  |  | - |  |  |  |  | (80 | ) |  |  | (279 | ) |  |  | - |  |  |  |  | (279 | )
Net income (loss) attributable to common stockholders |  |  | 1,151 |  |  |  | (25,696 | ) |  |  |  | (24,545 | ) |  |  | 2,094 |  |  |  | (48,311 | ) |  |  |  | (46,217 | )
Net income (loss) attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 1,151 |  |  | $ | (25,696 | ) |  |  | $ | (24,545 | ) |  | $ | 2,094 |  |  | $ | (48,311 | ) |  |  | $ | (46,217 | )
Diluted |  | $ | 1,151 |  |  | $ | (25,696 | ) |  |  | $ | (24,545 | ) |  | $ | 2,094 |  |  | $ | (48,311 | ) |  |  | $ | (46,217 | )
Earnings per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.07 |  |  | $ | (1.49 | ) |  |  | $ | (1.42 | ) |  | $ | 0.13 |  |  | $ | (3.11 | ) |  |  | $ | (2.98 | )
Diluted |  | $ | 0.05 |  |  | $ | (1.47 | ) |  |  | $ | (1.42 | ) |  | $ | 0.10 |  |  | $ | (3.08 | ) |  |  | $ | (2.98 | )
Weighted average shares used to compute earnings per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 17,273,412 |  |  |  | - |  |  |  |  | 17,273,412 |  |  |  | 15,529,026 |  |  |  | - |  |  |  |  | 15,529,026 |
Diluted |  |  | 23,656,633 |  |  |  | (6,383,221 | ) |  |  |  | 17,273,412 |  |  |  | 21,051,219 |  |  |  | (5,522,193 | ) |  |  |  | 15,529,026 |
(In thousands, except per share and share data) |  | Statement of Operations Three Months Ending March 31, 2019 |
|  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |
Revenue |  | $ | 5,770 |  |  | $ | - |  |  |  | $ | 5,770 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of revenue |  |  | 1,647 |  |  |  | - |  | (e) |  |  | 1,647 |
Research and development |  |  | 372 |  |  |  | (13 | ) | (d),(e) |  |  | 359 |
Sales and marketing |  |  | 848 |  |  |  | (11 | ) | (d),(e) |  |  | 837 |
General and administrative |  |  | 2,204 |  |  |  | (51 | ) | (d) |  |  | 2,153 |
Acquisition Costs |  |  | 208 |  |  |  | - |  |  |  |  | 208 |
Total operating expenses |  |  | 5,279 |  |  |  | (75 | ) |  |  |  | 5,204 |
Operating income (loss) |  |  | 491 |  |  |  | 75 |  |  |  |  | 566 |
Other income (expenses) |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of warrant liability |  |  | - |  |  |  | (19,663 | ) | (a) |  |  | (19,663 | )
Interest income |  |  | 171 |  |  |  | - |  |  |  |  | 171 |
Interest expense |  |  | (3 | ) |  |  | - |  |  |  |  | (3 | )
Loss from equity-method investment in SAVSU |  |  | (232 | ) |  |  | - |  |  |  |  | (232 | )
Total other income (expenses) |  |  | (64 | ) |  |  | (19,663 | ) |  |  |  | (19,727 | )
Income (loss) before provision for income taxes |  |  | 427 |  |  |  | (19,588 | ) |  |  |  | (19,161 | )
Income taxes |  |  | - |  |  |  | - |  |  |  |  | - |
Net income (loss) |  |  | 427 |  |  |  | (19,588 | ) |  |  |  | (19,161 | )
Net income (loss) attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 427 |  |  | $ | (19,588 | ) |  |  | $ | (19,161 | )
Diluted |  | $ | 427 |  |  | $ | (19,588 | ) |  |  | $ | (19,161 | )
Earnings per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.02 |  |  | $ | (1.05 | ) |  |  | $ | (1.03 | )
Diluted |  | $ | 0.02 |  |  | $ | (1.05 | ) |  |  | $ | (1.03 | )
Weighted average shares used to compute earnings per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 18,648,397 |  |  |  | - |  |  |  |  | 18,648,397 |
Diluted |  |  | 24,358,475 |  |  |  | (5,710,078 | ) |  |  |  | 18,648,397 |
(In thousands, except per share and share data) |  | Statement of Operation Three Months Ending June 30, 2019 |  |  | Statement of Operations Six Months Ending June 30, 2019 |
|  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |  |  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |
Revenue |  | $ | 6,701 |  |  | $ | - |  |  |  | $ | 6,701 |  |  | $ | 12,471 |  |  | $ | - |  |  |  | $ | 12,471 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of product revenue (exclusive of intangible assets amortization) |  |  | 1,958 |  |  |  | 10 |  | (d),(e) |  |  | 1,968 |  |  |  | 3,606 |  |  |  | 10 |  | (d),(e) |  |  | 3,616 |
Research and development |  |  | 739 |  |  |  | (48 | ) | (d),(e) |  |  | 691 |  |  |  | 1,111 |  |  |  | (61 | ) | (d),(e) |  |  | 1,050 |
Sales and marketing |  |  | 928 |  |  |  | 17 |  | (d),(e) |  |  | 945 |  |  |  | 1,776 |  |  |  | 6 |  | (d),(e) |  |  | 1,782 |
General and administrative |  |  | 2,118 |  |  |  | 89 |  | (d) |  |  | 2,207 |  |  |  | 4,321 |  |  |  | 38 |  | (d) |  |  | 4,359 |
Amort of Intangibles |  |  | - |  |  |  | 104 |  | (e) |  |  | 104 |  |  |  | - |  |  |  | 104 |  | (e) |  |  | 104 |
Acquisition Costs |  |  | 39 |  |  |  | - |  |  |  |  | 39 |  |  |  | 247 |  |  |  | - |  |  |  |  | 247 |
Total operating expenses |  |  | 5,782 |  |  |  | 172 |  |  |  |  | 5,954 |  |  |  | 11,061 |  |  |  | 97 |  |  |  |  | 11,158 |
Operating income (loss) |  |  | 919 |  |  |  | (172 | ) |  |  |  | 747 |  |  |  | 1,410 |  |  |  | (97 | ) |  |  |  | 1,313 |
Other income (expenses) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of warrant liability |  |  | - |  |  |  | 3,586 |  | (a) |  |  | 3,586 |  |  |  | - |  |  |  | (16,077 | ) | (a) |  |  | (16,077 | )
Interest income |  |  | 137 |  |  |  | - |  |  |  |  | 137 |  |  |  | 307 |  |  |  | - |  |  |  |  | 307 |
Interest expense |  |  | (1 | ) |  |  | - |  |  |  |  | (1 | ) |  |  | (4 | ) |  |  | - |  |  |  |  | (4 | )
Other Expense |  |  | - |  |  |  | - |  |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  | - |
Loss from equity-method investment in SAVSU |  |  | (217 | ) |  |  | - |  |  |  |  | (217 | ) |  |  | (448 | ) |  |  | - |  |  |  |  | (448 | )
Gain on Acquisition of SAVSU |  |  | - |  |  |  | - |  |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  | - |
Total other income (expenses) |  |  | (81 | ) |  |  | 3,586 |  |  |  |  | 3,505 |  |  |  | (145 | ) |  |  | (16,077 | ) |  |  |  | (16,222 | )
Income (loss) before provision for income taxes |  |  | 838 |  |  |  | 3,414 |  |  |  |  | 4,252 |  |  |  | 1,265 |  |  |  | (16,174 | ) |  |  |  | (14,909 | )
Income taxes |  |  | - |  |  |  | - |  |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  | - |
Net income (loss) |  |  | 838 |  |  |  | 3,414 |  |  |  |  | 4,252 |  |  |  | 1,265 |  |  |  | (16,174 | ) |  |  |  | (14,909 | )
Net income (loss) attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 838 |  |  | $ | 2,587 |  |  |  | $ | 3,425 |  |  | $ | 1,265 |  |  | $ | (16,174 | ) |  |  | $ | (14,909 | )
Diluted |  | $ | 838 |  |  | $ | (293 | ) |  |  | $ | 545 |  |  | $ | 1,265 |  |  | $ | (16,174 | ) |  |  | $ | (14,909 | )
Earnings per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.04 |  |  | $ | 0.14 |  |  |  | $ | 0.18 |  |  | $ | 0.07 |  |  | $ | (0.87 | ) |  |  | $ | (0.80 | )
Diluted |  | $ | 0.03 |  |  | $ | (0.01 | ) |  |  | $ | 0.02 |  |  | $ | 0.05 |  |  | $ | (0.85 | ) |  |  | $ | (0.80 | )
Weighted average shares used to compute earnings per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 18,819,459 |  |  |  | - |  |  |  |  | 18,819,459 |  |  |  | 18,734,401 |  |  |  | - |  |  |  |  | 18,734,401 |
Diluted |  |  | 24,539,299 |  |  |  | - |  |  |  |  | 24,539,299 |  |  |  | 24,439,959 |  |  |  | (5,705,558 | ) |  |  |  | 18,734,401 |
(In thousands, except per share and share data) |  | Statement of Operations Three Months Ending September 30, 2019 |  |  | Statement of Operations Nine Months Ending September 30, 2019 |
|  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |  |  | As Previously Reported |  |  | Adjustments |  |  |  | As Restated |
Revenue |  | $ | 6,604 |  |  | $ | - |  |  |  | $ | 6,604 |  |  | $ | 19,075 |  |  | $ | - |  |  |  | $ | 19,075 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of product and rental revenue (exclusive of intangible assets amortization) |  |  | 2,084 |  |  |  | 10 |  | (d),(e) |  |  | 2,094 |  |  |  | 5,690 |  |  |  | 20 |  | (d),(e) |  |  | 5,710 |
Research and development |  |  | 1,309 |  |  |  | (277 | ) | (d),(e) |  |  | 1,032 |  |  |  | 2,420 |  |  |  | (338 | ) | (d),(e) |  |  | 2,082 |
Sales and marketing |  |  | 1,259 |  |  |  | (9 | ) | (d),(e) |  |  | 1,250 |  |  |  | 3,035 |  |  |  | (3 | ) | (d),(e) |  |  | 3,032 |
General and administrative |  |  | 2,258 |  |  |  | 90 |  | (d) |  |  | 2,348 |  |  |  | 6,579 |  |  |  | 128 |  | (d) |  |  | 6,707 |
Amort of Intangibles |  |  | - |  |  |  | 361 |  | (e) |  |  | 361 |  |  |  | - |  |  |  | 465 |  | (e) |  |  | 465 |
Acquisition Costs |  |  | 291 |  |  |  | - |  |  |  |  | 291 |  |  |  | 538 |  |  |  | - |  |  |  |  | 538 |
Total operating expenses |  |  | 7,201 |  |  |  | 175 |  |  |  |  | 7,376 |  |  |  | 18,262 |  |  |  | 272 |  |  |  |  | 18,534 |
Operating income (loss) |  |  | (597 | ) |  |  | (175 | ) |  |  |  | (772 | ) |  |  | 813 |  |  |  | (272 | ) |  |  |  | 541 |
Other income (expenses) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of warrant liability |  |  | - |  |  |  | 1,128 |  | (a) |  |  | 1,128 |  |  |  | - |  |  |  | (14,949 | ) | (a) |  |  | (14,949 | )
Interest income |  |  | 110 |  |  |  | - |  |  |  |  | 110 |  |  |  | 417 |  |  |  | - |  |  |  |  | 417 |
Interest expense |  |  | (1 | ) |  |  | - |  |  |  |  | (1 | ) |  |  | (5 | ) |  |  | - |  |  |  |  | (5 | )
Other Expense |  |  | (13 | ) |  |  | - |  |  |  |  | (13 | ) |  |  | (13 | ) |  |  | - |  |  |  |  | (13 | )
Loss from equity-method investment in SAVSU |  |  | (291 | ) |  |  | - |  |  |  |  | (291 | ) |  |  | (739 | ) |  |  | - |  |  |  |  | (739 | )
Gain on Acquisition of SAVSU |  |  | 10,108 |  |  |  | - |  |  |  |  | 10,108 |  |  |  | 10,108 |  |  |  | - |  |  |  |  | 10,108 |
Total other income (expenses) |  |  | 9,913 |  |  |  | 1,128 |  |  |  |  | 11,041 |  |  |  | 9,768 |  |  |  | (14,949 | ) |  |  |  | (5,181 | )
Income (loss) before provision for income taxes |  |  | 9,316 |  |  |  | 953 |  |  |  |  | 10,269 |  |  |  | 10,581 |  |  |  | (15,221 | ) |  |  |  | (4,640 | )
Income taxes |  |  | - |  |  |  | - |  |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  | - |
Net income (loss) |  |  | 9,316 |  |  |  | 953 |  |  |  |  | 10,269 |  |  |  | 10,581 |  |  |  | (15,221 | ) |  |  |  | (4,640 | )
Net income (loss) attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 9,316 |  |  | $ | (936 | ) |  |  | $ | 8,380 |  |  | $ | 10,581 |  |  | $ | (15,221 | ) |  |  | $ | (4,640 | )
Diluted |  |  | 9,316 |  |  |  | (454 | ) |  |  |  | 8,862 |  |  |  | 10,581 |  |  |  | (15,221 | ) |  |  |  | (4,640 | )
Earnings per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.47 |  |  | $ | (0.05 | ) |  |  | $ | 0.42 |  |  | $ | 0.55 |  |  | $ | (0.79 | ) |  |  | $ | (0.24 | )
Diluted |  | $ | 0.37 |  |  | $ | (0.02 | ) |  |  | $ | 0.35 |  |  | $ | 0.43 |  |  | $ | (0.67 | ) |  |  | $ | (0.24 | )
Weighted average shares used to compute earnings per share attributable to common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 19,735,364 |  |  |  | - |  |  |  |  | 19,735,364 |  |  |  | 19,071,722 |  |  |  | - |  |  |  |  | 19,071,722 |
Diluted |  |  | 25,343,112 |  |  |  | - |  |  |  |  | 25,343,112 |  |  |  | 24,705,424 |  |  |  | (5,633,702 | ) |  |  |  | 19,071,722 |
|  | Three Months Ended March 30, 2018 |
(In thousands) |  | As Previously Reported |  |  | Adjustments |  |  |  | Restated |
Cash flows from operating activities |  |  |  |  |  |  |  |  |  |  |  |  |
Net income |  | $ | 3 |  |  | $ | 4,870 |  | (a) |  | $ | 4,873 |
Adjustments to reconcile net income to net cash provided by operating activities |  |  |  |  |  |  |  |  |  |  |  |  |
Depreciation |  |  | 78 |  |  |  | - |  |  |  |  | 78 |
Stock-based compensation |  |  | 373 |  |  |  | - |  |  |  |  | 373 |
Amortization of deferred rent related to lease incentives |  |  | (32 | ) |  |  | - |  |  |  |  | (32 | )
Amortization of debt discount |  |  | - |  |  |  | - |  |  |  |  | - |
Loss from equity method investment in SAVSU |  |  | 144 |  |  |  | - |  |  |  |  | 144 |
Change in fair value of warrant liability |  |  | - |  |  |  | (4,870 | ) | (a) |  |  | (4,870 | )
Change in operating assets and liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
(Increase) Decrease in |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts receivable, trade, net |  |  | (23 | ) |  |  | - |  |  |  |  | (23 | )
Inventories |  |  | 10 |  |  |  | - |  |  |  |  | 10 |
Prepaid expenses and other current assets |  |  | 12 |  |  |  | - |  |  |  |  | 12 |
(Increase) Decrease in |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  |  | (69 | ) |  |  | - |  |  |  |  | (69 | )
Accrued compensation and other current liabilities |  |  | (101 | ) |  |  | - |  |  |  |  | (101 | )
Deferred rent |  |  | (3 | ) |  |  | - |  |  |  |  | (3 | )
Net cash provided by operating activities |  |  | 392 |  |  |  | - |  |  |  |  | 392 |
Cash flows from investing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of property and equipment |  |  | (41 | ) |  |  | - |  |  |  |  | (41 | )
Net cash used in investing activities |  |  | (41 | ) |  |  | - |  |  |  |  | (41 | )
Cash flows from financing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Payments on equipment loan |  |  | (2 | ) |  |  | - |  |  |  |  | (2 | )
Payments on capital lease obligation |  |  | (3 | ) |  |  | - |  |  |  |  | (3 | )
Proceeds from exercise of common stock options and warrants |  |  | 130 |  |  |  | - |  |  |  |  | 130 |
Payments of preferred stock dividends |  |  | (106 | ) |  |  | - |  |  |  |  | (106 | )
Net cash provided by financing activities |  |  | 19 |  |  |  | - |  |  |  |  | 19 |
Net increase (decrease) in cash and cash equivalents |  |  | 370 |  |  |  | - |  |  |  |  | 370 |
|  |  |  |  |  |  |  |  |  |  |  | - |
Cash and cash equivalents – beginning of period |  |  | 6,663 |  |  |  | - |  |  |  |  | 6,663 |
Cash and cash equivalents – end of year |  | $ | 7,033 |  |  | $ | - |  |  |  | $ | 7,033 |
Non-cash investing and financing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued for services provided in prior period included in liabilities at year-end |  | $ | 36 |  |  | $ | - |  |  |  | $ | 36 |
Purchase of equipment with debt |  |  | 18 |  |  |  | - |  |  |  |  | 18 |
Series A preferred stock dividends accrued not yet paid |  |  | 106 |  |  |  | - |  |  |  |  | 106 |
Reclassification of warrant liabilities to equity upon exercise |  | $ | - |  |  | $ | 29 |  |  |  | $ | 29 |
|  | Six Months Ended June 30, 2018 |
(In thousands ) |  | As Previously Reported |  |  | Adjustments |  |  |  | Restated |
Cash flows from operating activities |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 1,143 |  |  | $ | (22,615 | ) | (a) |  | $ | (21,472 | )
Adjustments to reconcile net income (loss) to net cash provided by operating activities |  |  |  |  |  |  |  |  |  |  |  |  |
Depreciation |  |  | 161 |  |  |  | - |  |  |  |  | 161 |
Stock-based compensation |  |  | 748 |  |  |  | - |  |  |  |  | 748 |
Stock issued for services |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization of deferred rent related to lease incentives |  |  | (63 | ) |  |  | - |  |  |  |  | (63 | )
Loss from equity method investment in SAVSU |  |  | 321 |  |  |  | - |  |  |  |  | 321 |
Change in fair value of warrant liability |  |  | - |  |  |  | 22,615 |  | (a) |  |  | 22,615 |
Change in operating assets and liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
(Increase) Decrease in |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts receivable, trade, net |  |  | (1,145 | ) |  |  | - |  |  |  |  | (1,145 | )
Inventories |  |  | (275 | ) |  |  | - |  |  |  |  | (275 | )
Prepaid expenses and other current assets |  |  | (103 | ) |  |  | - |  |  |  |  | (103 | )
Accounts payable |  |  | 168 |  |  |  | - |  |  |  |  | 168 |
Accrued compensation and other current liabilities |  |  | 6 |  |  |  | - |  |  |  |  | 6 |
Deferred rent |  |  | (6 | ) |  |  | - |  |  |  |  | (6 | )
Net cash provided by operating activities |  |  | 955 |  |  |  | - |  |  |  |  | 955 |
Cash flows from investing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Investment in equity investment SAVSU |  |  | (1,000 | ) |  |  | - |  |  |  |  | (1,000 | )
Purchase of property and equipment |  |  | (61 | ) |  |  | - |  |  |  |  | (61 | )
Net cash used in investing activities |  |  | (1,061 | ) |  |  | - |  |  |  |  | (1,061 | )
Cash flows from financing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Payments on equipment loan |  |  | (5 | ) |  |  | - |  |  |  |  | (5 | )
Payments on capital lease obligation |  |  | (7 | ) |  |  | - |  |  |  |  | (7 | )
Proceeds from exercise of common stock options and warrants |  |  | 8,899 |  |  |  | - |  |  |  |  | 8,899 |
Payments of preferred stock dividends |  |  | (213 | ) |  |  | - |  |  |  |  | (213 | )
Payments for redemption of preferred stock |  |  | (1,063 | ) |  |  | - |  |  |  |  | (1,063 | )
Net cash provided by financing activities |  |  | 7,611 |  |  |  | - |  |  |  |  | 7,611 |
Net increase (decrease) in cash and cash equivalents |  |  | 7,505 |  |  |  | - |  |  |  |  | 7,505 |
|  |  |  |  |  |  |  |  |  |  |  | - |
Cash and cash equivalents – beginning of period |  |  | 6,663 |  |  |  | - |  |  |  |  | 6,663 |
Cash and cash equivalents – end of year |  | $ | 14,168 |  |  | $ | - |  |  |  | $ | 14,168 |
Non-cash investing and financing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Series A preferred stock dividends accrued not yet paid |  | $ | 93 |  |  | $ | - |  |  |  | $ | 93 |
Stock issued for services provided in prior period included in liabilities at year-end |  |  | 36 |  |  |  | - |  |  |  |  | 36 |
Receivables converted to equity investment in SAVSU |  |  | 150 |  |  |  | - |  |  |  |  | 150 |
Purchase of equipment with debt |  |  | 18 |  |  |  | - |  |  |  |  | 18 |
Purchase of property and equipment not yet paid |  |  | 20 |  |  |  | - |  |  |  |  | 20 |
Reclassification of warrant liabilities to equity upon exercise |  | $ | - |  |  | $ | 9,639 |  |  |  | $ | 9,639 |
|  | Nine Months Ended September 30, 2018 |
(In thousands) |  | As Previously Reported |  |  | Adjustments |  |  |  | Restated |
Cash flows from operating activities |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 2,373 |  |  | $ | (48,311 | ) | (a) |  | $ | (45,938 | )
Adjustments to reconcile net income (loss) to net cash provided by operating activities |  |  |  |  |  |  |  |  |  |  |  |  |
Depreciation |  |  | 245 |  |  |  | - |  |  |  |  | 245 |
Stock-based compensation |  |  | 1,131 |  |  |  | - |  |  |  |  | 1,131 |
Stock issued for services |  |  |  |  |  |  |  |  |  |  |  |  |
Write off of deferred financing costs |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization of deferred rent related to lease incentives |  |  | (95 | ) |  |  | - |  |  |  |  | (95 | )
Loss from equity method investment in SAVSU |  |  | 363 |  |  |  | - |  |  |  |  | 363 |
Change in fair value of warrant liability |  |  | - |  |  |  | 48,311 |  | (a) |  |  | 48,311 |
Change in operating assets and liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
(Increase) Decrease in |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts receivable, trade, net |  |  | (1,678 | ) |  |  | - |  |  |  |  | (1,678 | )
Inventories |  |  | (1,064 | ) |  |  | - |  |  |  |  | (1,064 | )
Prepaid expenses and other current assets |  |  | (49 | ) |  |  | - |  |  |  |  | (49 | )
Accounts payable |  |  | 343 |  |  |  | - |  |  |  |  | 343 |
Accrued compensation and other current liabilities |  |  | 205 |  |  |  | - |  |  |  |  | 205 |
Deferred rent |  |  | (11 | ) |  |  | - |  |  |  |  | (11 | )
Net cash provided by operating activities |  |  | 1,763 |  |  |  | - |  |  |  |  | 1,763 |
Cash flows from investing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Investment in equity investment SAVSU |  |  | (6,000 | ) |  |  | - |  |  |  |  | (6,000 | )
Purchase of property and equipment |  |  | (339 | ) |  |  | - |  |  |  |  | (339 | )
Net cash used in investing activities |  |  | (6,339 | ) |  |  | - |  |  |  |  | (6,339 | )
Cash flows from financing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from private equity transaction |  |  | 20,000 |  |  |  | - |  |  |  |  | 20,000 |
Payments on equipment loan |  |  | (9 | ) |  |  | - |  |  |  |  | (9 | )
Payments on capital lease obligation |  |  | (10 | ) |  |  | - |  |  |  |  | (10 | )
Proceeds from exercise of common stock options and warrants |  |  | 11,725 |  |  |  | - |  |  |  |  | 11,725 |
Payments of preferred stock dividends |  |  | (306 | ) |  |  | - |  |  |  |  | (306 | )
Payments for redemption of preferred stock |  |  | (1,063 | ) |  |  | - |  |  |  |  | (1,063 | )
Deferred costs related to security issuance |  |  | (43 | ) |  |  | - |  |  |  |  | (43 | )
Net cash provided by financing activities |  |  | 30,294 |  |  |  | - |  |  |  |  | 30,294 |
Net increase (decrease) in cash and cash equivalents |  |  | 25,718 |  |  |  | - |  |  |  |  | 25,718 |
|  |  |  |  |  |  |  |  |  |  |  | - |
Cash and cash equivalents – beginning of period |  |  | 6,663 |  |  |  | - |  |  |  |  | 6,663 |
Cash and cash equivalents – end of year |  | $ | 32,381 |  |  | $ | - |  |  |  | $ | 32,381 |
Non-cash investing and financing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Series A preferred stock dividends accrued not yet paid |  | $ | 80 |  |  | $ | - |  |  |  | $ | 80 |
Stock issued for services provided in prior period included in liabilities at year-end |  |  | 36 |  |  |  | - |  |  |  |  | 36 |
Receivables converted to equity investment in SAVSU |  |  | 150 |  |  |  | - |  |  |  |  | 150 |
Purchase of equipment with debt |  |  | 18 |  |  |  | - |  |  |  |  | 18 |
Legal fees for private equity transaction not yet paid |  |  | 43 |  |  |  | - |  |  |  |  | 43 |
Purchase of property and equipment not yet paid |  |  | 49 |  |  |  | - |  |  |  |  | 49 |
Reclassification of warrant liabilities to equity upon exercise |  | $ | - |  |  | $ | 17,509 |  |  |  | $ | 17,509 |
|  | Three Months Ended March 30, 2019 |
(In thousands) |  | As Previously Reported |  |  | Adjustments |  |  |  | Restated |
Cash flows from operating activities |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 427 |  |  | $ | (19,588 | ) | (a) |  | $ | (19,161 | )
Adjustments to reconcile net income (loss) to net cash provided by operating activities |  |  |  |  |  |  |  |  |  |  |  |  |
Depreciation |  |  | 98 |  |  |  | - |  |  |  |  | 98 |
Stock-based compensation |  |  | 606 |  |  |  | (75 | ) | (d) |  |  | 531 |
Amortization of operating lease liability |  |  | (43 | ) |  |  | - |  |  |  |  | (43 | )
Interest expense - finance type lease |  |  | 2 |  |  |  | - |  |  |  |  | 2 |
Loss from equity method investment in SAVSU |  |  | 232 |  |  |  | - |  |  |  |  | 232 |
Change in fair value of warrant liability |  |  | - |  |  |  | 19,663 |  | (a) |  |  | 19,663 |
Change in operating assets and liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
(Increase) Decrease in |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts receivable, trade, net |  |  | 118 |  |  |  | - |  |  |  |  | 118 |
Inventories |  |  | (551 | ) |  |  | - |  |  |  |  | (551 | )
Prepaid expenses and other current assets |  |  | 6 |  |  |  | - |  |  |  |  | 6 |
(Increase) Decrease in |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  |  | 553 |  |  |  | - |  |  |  |  | 553 |
Accrued compensation and other current liabilities |  |  | (302 | ) |  |  | - |  |  |  |  | (302 | )
Net cash provided by operating activities |  |  | 1,146 |  |  |  | - |  |  |  |  | 1,146 |
Cash flows from investing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of property and equipment |  |  | (156 | ) |  |  | - |  |  |  |  | (156 | )
Net cash used in investing activities |  |  | (156 | ) |  |  | - |  |  |  |  | (156 | )
Cash flows from financing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Payments on equipment loan |  |  | (4 | ) |  |  | - |  |  |  |  | (4 | )
Payments on capital lease obligation |  |  | (4 | ) |  |  | - |  |  |  |  | (4 | )
Proceeds from exercise of common stock options and warrants |  |  | 185 |  |  |  | - |  |  |  |  | 185 |
Net cash provided by financing activities |  |  | 177 |  |  |  | - |  |  |  |  | 177 |
Net increase (decrease) in cash and cash equivalents |  |  | 1,167 |  |  |  | - |  |  |  |  | 1,167 |
Cash and cash equivalents – beginning of period |  |  | 30,657 |  |  |  | - |  |  |  |  | 30,657 |
Cash and cash equivalents – end of year |  | $ | 31,824 |  |  | $ | - |  |  |  | $ | 31,824 |
Non-cash investing and financing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued for services provided in prior period included in liabilities at year-end |  | $ | - |  |  | $ | - |  |  |  | $ | - |
Purchase of equipment with debt |  |  | - |  |  |  | - |  |  |  |  | - |
Series A preferred stock dividends accrued not yet paid |  |  | - |  |  |  | - |  |  |  |  | - |
Purchase of property and equipment not yet paid |  |  | 46 |  |  |  | - |  |  |  |  | 46 |
Reclassification of warrant liabilities to equity upon exercise |  | $ | - |  |  | $ | 73 |  |  |  | $ | 73 |
|  | Six Months Ended June 30, 2019 |
(In thousands) |  | As Previously Reported |  |  | Adjustments |  |  |  | Restated |
Cash flows from operating activities |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 1,265 |  |  | $ | (16,174 | ) | (a) |  | $ | (14,909 | )
Adjustments to reconcile net income (loss) to net cash provided by operating activities |  |  |  |  |  |  |  |  |  |  |  |  |
Depreciation |  |  | 209 |  |  |  | - |  |  |  |  | 209 |
Stock-based compensation |  |  | 1,252 |  |  |  | 97 |  | (d) |  |  | 1,349 |
Amortization of deferred rent related to lease incentives |  |  | - |  |  |  | - |  |  |  |  | - |
Amortization of operating lease liability |  |  | (87 | ) |  |  | - |  |  |  |  | (87 | )
Interest expense - finance type lease |  |  | 2 |  |  |  | - |  |  |  |  | 2 |
Loss from equity method investment in SAVSU |  |  | 448 |  |  |  | - |  |  |  |  | 448 |
Amortization of intangible assets |  |  | 104 |  |  |  | - |  |  |  |  | 104 |
Change in fair value of warrant liability |  |  | - |  |  |  | 16,077 |  | (a) |  |  | 16,077 |
Change in operating assets and liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
(Increase) Decrease in |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts receivable, trade, net |  |  | (632 | ) |  |  | - |  |  |  |  | (632 | )
Inventories |  |  | (1,341 | ) |  |  | - |  |  |  |  | (1,341 | )
Prepaid expenses and other current assets |  |  | (32 | ) |  |  | - |  |  |  |  | (32 | )
(Increase) Decrease in |  |  |  |  |  |  |  |  |  |  |  | - |
Accounts payable |  |  | (36 | ) |  |  | - |  |  |  |  | (36 | )
Accrued compensation and other current liabilities |  |  | (20 | ) |  |  | - |  |  |  |  | (20 | )
Deferred rent |  |  | - |  |  |  | - |  |  |  |  | - |
Other liabilities |  |  | (53 | ) |  |  | - |  |  |  |  | (53 | )
Net cash provided by operating activities |  |  | 1,079 |  |  |  | - |  |  |  |  | 1,079 |
Cash flows from investing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Payments related to the Astero Bio Acquisition, net of cash acquired |  |  | (12,438 | ) |  |  | - |  |  |  |  | (12,438 | )
Investment in equity investment SAVSU |  |  | - |  |  |  | - |  |  |  |  | - |
Purchase of property and equipment |  |  | (267 | ) |  |  | - |  |  |  |  | (267 | )
Net cash used in investing activities |  |  | (12,705 | ) |  |  | - |  |  |  |  | (12,705 | )
Cash flows from financing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Payments on equipment loan |  |  | (8 | ) |  |  | - |  |  |  |  | (8 | )
Payments on capital lease obligation |  |  | (7 | ) |  |  | - |  |  |  |  | (7 | )
Proceeds from exercise of common stock options and warrants |  |  | 600 |  |  |  | - |  |  |  |  | 600 |
Net cash provided by financing activities |  |  | 585 |  |  |  | - |  |  |  |  | 585 |
Net increase (decrease) in cash and cash equivalents |  |  | (11,041 | ) |  |  | - |  |  |  |  | (11,041 | )
Cash and cash equivalents – beginning of period |  |  | 30,657 |  |  |  | - |  |  |  |  | 30,657 |
Cash and cash equivalents – end of year |  | $ | 19,616 |  |  | $ | - |  |  |  | $ | 19,616 |
Non-cash investing and financing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Series A preferred stock dividends accrued not yet paid |  | $ | - |  |  | $ | - |  |  |  | $ | - |
Stock issued for services provided in prior period included in liabilities at year-end |  |  | - |  |  |  | - |  |  |  |  | - |
Receivables converted to equity investment in SAVSU |  |  | - |  |  |  | - |  |  |  |  | - |
Purchase of equipment with debt |  |  | - |  |  |  | - |  |  |  |  | - |
Purchase of property and equipment not yet paid |  |  | 4 |  |  |  | - |  |  |  |  | 4 |
Reclassification of warrant liabilities to equity upon exercise |  | $ | - |  |  | $ | 400 |  |  |  | $ | 400 |
|  | Nine Months Ended September 30, 2019 |
(In thousands) |  | As Previously Reported |  |  | Adjustments |  |  |  | Restated |
Cash flows from operating activities |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 10,581 |  |  | $ | (15,221 | ) | (a) |  | $ | (4,640 | )
Adjustments to reconcile net income (loss) to net cash provided by operating activities |  |  |  |  |  |  |  |  |  |  |  |  |
Depreciation |  |  | 373 |  |  |  | - |  |  |  |  | 373 |
Loss on disposal of property and equipment |  |  | 13 |  |  |  | - |  |  |  |  | 13 |
Stock-based compensation |  |  | 1,907 |  |  |  | 272 |  | (d) |  |  | 2,179 |
Amortization of operating lease liability |  |  | (132 | ) |  |  | - |  |  |  |  | (132 | )
Interest expense - finance type lease |  |  | 2 |  |  |  | - |  |  |  |  | 2 |
Loss from equity method investment in SAVSU |  |  | 739 |  |  |  | - |  |  |  |  | 739 |
Gain on acquisition of SAVSU |  |  | (10,108 | ) |  |  | - |  |  |  |  | (10,108 | )
Amortization of intangible assets |  |  | 465 |  |  |  | - |  |  |  |  | 465 |
Change in fair value of warrant liability |  |  | - |  |  |  | 14,949 |  | (a) |  |  | 14,949 |
Change in operating assets and liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
(Increase) Decrease in |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts receivable, trade, net |  |  | (372 | ) |  |  | - |  |  |  |  | (372 | )
Inventories |  |  | (1,730 | ) |  |  | - |  |  |  |  | (1,730 | )
Prepaid expenses and other current assets |  |  | (272 | ) |  |  | - |  |  |  |  | (272 | )
Other assets, net |  |  | (87 | ) |  |  | - |  |  |  |  | (87 | )
(Increase) Decrease in |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  |  | 377 |  |  |  | - |  |  |  |  | 377 |
Accrued compensation and other current liabilities |  |  | 558 |  |  |  | - |  |  |  |  | 558 |
Other liabilities |  |  | (98 | ) |  |  | - |  |  |  |  | (98 | )
Net cash provided by operating activities |  |  | 2,216 |  |  |  | - |  |  |  |  | 2,216 |
Cash flows from investing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Cash acquired on acquisition of SAVSU |  |  | 1,251 |  |  |  | - |  |  |  |  | 1,251 |
Payments related to the Astero Bio Acquisition, net of cash acquired |  |  | (12,439 | ) |  |  | - |  |  |  |  | (12,439 | )
Investment in iVexSol |  |  | (1,000 | ) |  |  | - |  |  |  |  | (1,000 | )
Purchase of property and equipment |  |  | (356 | ) |  |  | - |  |  |  |  | (356 | )
Purchase of assets held for rent |  |  | (453 | ) |  |  | - |  |  |  |  | (453 | )
Net cash used in investing activities |  |  | (12,997 | ) |  |  | - |  |  |  |  | (12,997 | )
Cash flows from financing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from private equity transaction |  |  |  |  |  |  | - |  |  |  |  | - |
Payments of costs related to Stock Issuances |  |  | (44 | ) |  |  | - |  |  |  |  | (44 | )
Payments on equipment loan |  |  | (12 | ) |  |  | - |  |  |  |  | (12 | )
Payments on finance lease obligation |  |  | (9 | ) |  |  | - |  |  |  |  | (9 | )
Proceeds from exercise of common stock options and warrants |  |  | 1,394 |  |  |  | - |  |  |  |  | 1,394 |
Net cash provided by financing activities |  |  | 1,329 |  |  |  | - |  |  |  |  | 1,329 |
Net increase (decrease) in cash and cash equivalents |  |  | (9,452 | ) |  |  | - |  |  |  |  | (9,452 | )
|  |  |  |  |  |  |  |  |  |  |  | - |
Cash and cash equivalents – beginning of period |  |  | 30,657 |  |  |  | - |  |  |  |  | 30,657 |
Cash and cash equivalents – end of year |  | $ | 21,205 |  |  | $ | - |  |  |  | $ | 21,205 |
Non-cash investing and financing activities |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of equipment with debt |  | $ | 146 |  |  | $ | - |  |  |  | $ | 146 |
Purchase of property and equipment not yet paid |  |  | 53 |  |  |  | - |  |  |  |  | 53 |
Stock issued as consideration to acquire SAVSU |  |  | 19,932 |  |  |  | - |  |  |  |  | 19,932 |
Reclassification of warrant liabilities to equity upon exercise |  | $ | - |  |  | $ | 1,695 |  |  |  | $ | 1,695 |

X
- Definition Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration